actinic keratosis

Clarifying ingenol labeling changesConcerns have been raised over an FDA Drug Safety Communication about spontaneously submitted adverse reactions in patients using this topical treatment for actinic keratosis as well as labeling changes that were implemented because of those reports. One expert offers perspective.
Cutting edge techniques provide options for skin cancerNew technologies for managing skin cancer were a topic of discussion at a scientific session at the American Society for Dermatologic Surgery’s 2015 annual meeting in Chicago in October. Seaver L. Soon, M.D., division of dermatology and dermatologic surgery at Scripps Clinic, La Jolla, Calif., was one of the moderators for the scientific discussion titled, “The Cutting Edge: New Technologies for Managing Skin Cancer.” Learn more
6 important trends in PDT treatment for AKSeveral “What’s New” factors will help dermatologists optimize photodynamic therapy in the treatment of actinic keratoses.
More common sense needed in treating AKsNeal Bhatia, M.D., asked attendees to consider why they treat AKs and challenged them to think of more strategies for preventing and minimizing treatment problems.
Actinic Keratosis (Precancerous Skin Cancer) on The Dr. Bob Show (VIDEO)Dr. Meredith Overholt, Board Certified Dermatologist, shows several pictures of actinic keratosis and explains how this condition is treated. Video by The Dr. Bob Show on the DrBobShow1 YouTube channel.
PDT superior to cryotherapy for clearing actinic keratosesPhotodynamic therapy (PDT) provided a better chance of complete lesion clearance in the treatment of actinic keratoses (AKs) when compared to treatment with cyrotherapy, according to results of a recent study.
La Roche-Posay announces research award winnersLa Roche-Posay has announced the recipients of the ninth annual La Roche-Posay North American Foundation 2014 Research Awards, celebrating advances in clinical, biological and pharmacological research advances in the field of dermatology.
Update: Actinic Keratoses | Guidelines aim to standardize, advance actinic keratoses treatments
Update: Actinic Keratoses | Guidelines aim to standardize, advance actinic keratoses treatmentsDermatologists and other medical specialists around the world who treat patients with actinic keratoses (AKs or solar keratoses) will soon be able to refer to new evidence-based (S3) guidelines for management.
Rising skin cancer rate spurs drive for new therapies
Rising skin cancer rate spurs drive for new therapiesThe commercialization of ingenol mebutate (Picato, LEO Pharma) a medication that is currently approved in the United States and many other countries for the treatment of actinic keratosis, is an example of how enthusiasm and commitment can drive innovation, a LEO Pharma general manager says.
5 clinical pearls for treating facial actinic keratoses
5 clinical pearls for treating facial actinic keratosesAt the MauiDerm 2014 meeting, conference organizer George Martin, M.D., shared five clinical pearls for treating facial actinic keratosis (AK).